Advances in Rheumatology (Jan 2021)

Abdominal symptoms during Sjogren’s syndrome: a pilot study

  • Simon Parreau,
  • Jérémie Jacques,
  • Stéphanie Dumonteil,
  • Sylvain. Palat,
  • Sophie Geyl,
  • Guillaume Gondran,
  • Holy Bezanahary,
  • Eric Liozon,
  • Julie Azaïs,
  • Stéphanie Colombie,
  • Marie-Odile Jauberteau,
  • Véronique Loustaud-Ratti,
  • Kim-Heang Ly,
  • Anne-Laure Fauchais

DOI
https://doi.org/10.1186/s42358-021-00164-w
Journal volume & issue
Vol. 61, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Background Abdominal symptoms in patients with primary Sjögren syndrome (pSS) are poorly documented. The objective of the study was to describe the abdominal symptoms of patients with pSS and to assess their association with characteristics of the disease. Methods One hundred and fifty patients with pSS were evaluated using a composite global symptom score for abdominal symptoms and their severity. Data concerning the clinical and biological characteristics of pSS and abdominal disorders were also collected. Results Of the patients with pSS, 95% suffered from abdominal symptoms (median global symptom score 7.5 ± 5.5 points out of 30). More than half of the patients experienced abdominal tension (68%), upper abdominal pain (54%), abdominal discomfort (58%) and/or constipation (54%). Regarding the pSS activity, in relation to European League Against Rheumatism (EULAR) Sjögren syndrome disease activity index score items, general and central nervous system involvement wereassociated with a high global symptom score. The EULAR Sjogren Syndrome Patient Reported Index (ESSPRI) symptom score was positively correlated with the global symptom score (p < 0.01). Multivariate analysis showed a significant association between a high global symptom score and SSA seronegativity, gastroparesis, and ESSPRI score (p < 0.01 for each). Conclusions The majority of patients with pSS suffered abdominal symptoms. There is currently no therapeutic recommendation because of the lack of information on the underlying pathophysiological mechanisms. Trial registration NCT03157011 . Date of registration: July 17, 2017.

Keywords